Cats and Permethrin Toxicity

Dymond NL, Swift IM. Permethrin toxicity in cats: a retrospective study of 20 cases. Aust Vet J. Jun 2008;86(6):219-223.

Researchers in Australia completed a retrospective study of 20 cases of permethrin toxicity in cats. The cats were presented to an emergency clinic in Brisbane, Australia from October 2004 to June 2005. Permethrin is present in many topical flea control products used for small animals. Cats are particularly susceptible to the toxic effects of permethrin, which occurs when cats are accidentally exposed to products made for use on dogs. The history of recent exposure plus typical clinical signs of permethrin poisoning including tremors, muscle fasciculations, and seizures were the primary means for diagnosis. Treatment included decontamination of the product and patient support with drug therapy to control muscle tremors and seizures. Researchers noted that rapid intervention lead to good outcomes of treatment in 19 of 20 cats. One kitten died when there was a 24-hour delay in treatment. All recovered cats were reported to have no complications when a 4-month follow-up was performed. Education of owners regarding the risks of permethrin use on cats plus clear, appropriate labeling of products to help decrease the number of future cases were the conclusions drawn by the study.
>> PubMed Abstract

Related articles:
Sutton NM, Bates N, Campbell A. Clinical effects and outcome of feline permethrin spot-on poisonings reported to the Veterinary Poisons Information Service (VPIS), London. J Feline Med Surg. Aug 2007;9(4):335-339.
>> PubMed Abstract

Linnett PJ. Permethrin toxicosis in cats. Aust Vet J. Jan-Feb 2008;86(1-2):32-35.
>> PubMed Abstract

More on cat health: Winn Feline Foundation Library

Dymond NL, Swift IM. Permethrin toxicity in cats: a retrospective study of 20 cases. Aust Vet J. Jun 2008;86(6):219-223.

Researchers in Australia completed a retrospective study of 20 cases of permethrin toxicity in cats. The cats were presented to an emergency clinic in Brisbane, Australia from October 2004 to June 2005. Permethrin is present in many topical flea control products used for small animals. Cats are particularly susceptible to the toxic effects of permethrin, which occurs when cats are accidentally exposed to products made for use on dogs. The history of recent exposure plus typical clinical signs of permethrin poisoning including tremors, muscle fasciculations, and seizures were the primary means for diagnosis. Treatment included decontamination of the product and patient support with drug therapy to control muscle tremors and seizures. Researchers noted that rapid intervention lead to good outcomes of treatment in 19 of 20 cats. One kitten died when there was a 24-hour delay in treatment. All recovered cats were reported to have no complications when a 4-month follow-up was performed. Education of owners regarding the risks of permethrin use on cats plus clear, appropriate labeling of products to help decrease the number of future cases were the conclusions drawn by the study.
>> PubMed Abstract

Related articles:
Sutton NM, Bates N, Campbell A. Clinical effects and outcome of feline permethrin spot-on poisonings reported to the Veterinary Poisons Information Service (VPIS), London. J Feline Med Surg. Aug 2007;9(4):335-339.
>> PubMed Abstract

Linnett PJ. Permethrin toxicosis in cats. Aust Vet J. Jan-Feb 2008;86(1-2):32-35.
>> PubMed Abstract

More on cat health: Winn Feline Foundation Library

Read More

Injection-Site Sarcomas

Shaw SC, Kent MS, Gordon IK, et al. Temporal changes in characteristics of injection-site sarcomas in cats: 392 cases (1990-2006). Journal of the American Veterinary Medical Association. 2009;234(3):376-380.

A proposed association between vaccinations and tumor formation in cats was first discussed in 1991. Studies since that time have supported a link between injections and the development of sarcomas. Fibrosarcomas are highly invasive and about 1/4 will metastasize. Radical surgery in combination with radiation therapy is required to control these tumors. In 1996, the Vaccine-Associated Feline Sarcoma Task Force (VAFSTF) was formed to identify methods to prevent and treat these tumors. One recommendation was to administer vaccinations to cats in standardized sites, avoiding the interscapular area. The purpose of this study was to evaluate changes in anatomic location and histologic classification of injection-site sarcomas, as well as signalment of affected cats before and after publication of the VAFSTF recommendations. In this retrospective case series, medical records of 392 cats with a diagnosis of sarcoma at a potential injection site were examined. From before to after the publication of the VAFSTF recommendations, the proportions of injection site-sarcomas significantly decreased in the interscapular and thoracic regions. However, proportions of the tumors in other locations significantly increased. Despite the recommendations, a high proportion of tumors still developed in the interscapular region. The researchers concluded that veterinarians are complying with the recommendations to some extent, but should ensure vaccinations are administered as distally as possible on a limb to allow for complete surgical excision should a tumor develop.
>> JAVMA Abstract

Related articles:
Romanelli G, Marconato L, Olivero D, Massari F, Zini E. Analysis of prognostic factors associated with injection-site sarcomas in cats: 57 cases (2001-2007). J Am Vet Med Assoc. 2008 Apr 15;232(8):1193-9.
>> PubMed Abstract

More on cat health: Winn Feline Foundation Library

Shaw SC, Kent MS, Gordon IK, et al. Temporal changes in characteristics of injection-site sarcomas in cats: 392 cases (1990-2006). Journal of the American Veterinary Medical Association. 2009;234(3):376-380.

A proposed association between vaccinations and tumor formation in cats was first discussed in 1991. Studies since that time have supported a link between injections and the development of sarcomas. Fibrosarcomas are highly invasive and about 1/4 will metastasize. Radical surgery in combination with radiation therapy is required to control these tumors. In 1996, the Vaccine-Associated Feline Sarcoma Task Force (VAFSTF) was formed to identify methods to prevent and treat these tumors. One recommendation was to administer vaccinations to cats in standardized sites, avoiding the interscapular area. The purpose of this study was to evaluate changes in anatomic location and histologic classification of injection-site sarcomas, as well as signalment of affected cats before and after publication of the VAFSTF recommendations. In this retrospective case series, medical records of 392 cats with a diagnosis of sarcoma at a potential injection site were examined. From before to after the publication of the VAFSTF recommendations, the proportions of injection site-sarcomas significantly decreased in the interscapular and thoracic regions. However, proportions of the tumors in other locations significantly increased. Despite the recommendations, a high proportion of tumors still developed in the interscapular region. The researchers concluded that veterinarians are complying with the recommendations to some extent, but should ensure vaccinations are administered as distally as possible on a limb to allow for complete surgical excision should a tumor develop.
>> JAVMA Abstract

Related articles:
Romanelli G, Marconato L, Olivero D, Massari F, Zini E. Analysis of prognostic factors associated with injection-site sarcomas in cats: 57 cases (2001-2007). J Am Vet Med Assoc. 2008 Apr 15;232(8):1193-9.
>> PubMed Abstract

More on cat health: Winn Feline Foundation Library

Read More